Profile of Patients of Hepatocellular Carcinoma in The Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital
Downloads
Introduction: Primary liver cancer is the sixth most frequently diagnosed cancer and the third leading cause of cancer death worldwide in 2020, with approximately 906,000 new cases and 830,000 deaths. Primary liver cancer includes hepatocellular carcinoma (HCC), with a percentage of 75%-85% of cases. The poor prognosis of HCC is mainly related to late diagnosis.
Methods: This research is a descriptive study with a cross-sectional study. Data retrieval is taken from secondary data in the form of medical record data. The sampling technique used was the total sampling technique.
Results: The number of HCC patients in the Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital for 1 January 2017–31 December 2019 who met the inclusion and exclusion criteria was 60. The male sex had the highest number of 43 patients (71.7%), with the highest age group being 50-59 years old.
Conclusion: Profile of HCC patients in the Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital for the 2017-2019 period, the largest age group was 50-59 years, dominated by male sex, the most risk factors were HBsAg positive, high liver function tests, high tumor markers, and had BCLC stage C. The patient had a live clinical outcome.
Abdelmoez FA, Imam HM, Idriss NK, et al. 2019. The role of hepatitis C virus and possible risk factors in development of hepatocellular carcinoma: 400 Patients based study. The Egyptian Journal of Internal Medicine 31:64–72. https://doi.org/10.4103/ejim.ejim_50_18.
Akkiz H, Carr B, Yalçın KK, et al. 2017. Characteristics of hepatocellular carcinoma aggressiveness factors in turkish patients. Oncology 94(2):116-124. https://doi.org/10.1159/000484564.
Aljumah AA, Kuriry H, AlZunaitan M, et al. 2016. Clinical presentation, risk factors, and treatment modalities of hepatocellular carcinoma: a single tertiary care center experience. Gastroenterology Research and Practice 2016:1989045. https://doi.org/10.1155/2016/1989045
Anggraini D. 2019. Laboratory examination in hepatocelullar carcinoma. Health & Medical Journal 1(2):50-53. https://doi.org/10.33854/heme.v1i2.241.
Axley P, Ahmed Z, Ravi S, et al. 2017. Hepatitis C virus and hepatocellular carcinoma: a narrative review. Journal of Clinical and Translational Hepatology 6(2):79-84. https://doi.org/10.14218/JCTH.2017.00067.
Ayoub WS, Steggerda J, Yang JD, et al. 2019. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers. Therapeutic Advances in Medical Oncology 11:175883591986912. https://doi.org/10.1177/1758835919869120.
Bağırsakçı E, Şahin E, Atabey N, et al. 2017. Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology 93(2):136–142. https://doi.org/10.1159/000471807.
Bodzin AS and Busuttil RW. 2015. Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome. World Journal of Hepatology 7(9):1157– 1167. https://doi.org/10.4254/wjh.v7.i9.1157.
Carr BI, She WH, Dai WC, et al. 2019. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy-an analysis of 1,182 patients in Hong Kong. Translational Gastroenterology and Hepatology 4(2):252-258. https://doi.org/10.21037/tgh.2019.06.07.
Chan MY, She WH, Dai WC, et al. 2019. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong. Translational Gastroenterology and Hepatology 4:52. https://doi.org/10.21037/tgh.2019.06.07.
Chen H, Chen X, Wang G. 2020. Platelets: a review of their function and effects in liver diseases. Liver Research 4(3):129-135. https://doi.org/10.1016/j.livres.2020.08.002.
Chung GE, Yim JY, Kim D, et al. 2016. Associations between white blood cell count and the development of incidental nonalcoholic fatty liver disease. Gastroenterology Research and Practice 2016:7653689. https://doi.org/10.1155/2016/7653689.
Dimitroulis D, Damaskos C, Valsami S, et al. 2017. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World Journal of Gastroenterology 23(29):5282–5294. https://doi.org/10.3748/wjg.v23.i29.5282.
European Association for the Study of the Liver. 2018. EASL Clinical practice guidelines: management of hepatocellular carcinoma. Available at https://www.journal-of-hepatology.eu/article/S0168-8278(18)30215-0/pdf. Accessed on 18 August 2020.
Finkelmeier F, Bettinger D, Köberle V, et al. 2014. Single measurement of hemoglobin predicts outcome of HCC patients. Medical Oncology 31(1):806. https://doi.org/10.1007/s12032-013- 0806-2.
Jaka H, Mshana SE, Rambau PF, et al. 2014. Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting. World Journal of Surgical Oncology 12:246. https://doi.org/10.1186/1477-7819-12-246.
Jasirwan COM, Hasan I, Sulaiman AS, et al. 2019. Risk factors for hepatocellular carcinoma and its mortality rate: a multicenter study in Indonesia. Archives in Cancer Research 7(1):1-7. DOI: 10.21767/2254- 6081.100191.
Kew MC. 2014. Hepatocellular carcinoma: epidemiology and risk factors. Journal of Hepatocellular Carcinoma 1:115–125. https://doi.org/10.2147/JHC.S44381.
Kumar R, Saraswat M, Sharma B, at al. 2008. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM 101(6):479-485.
Laube R, Sabih A, Strasser SI, et al. 2020. Palliative care in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 36(3):618-628. https://doi.org/10.1111/jgh.15169.
Magnussen A and Parsi MA. 2013. Aflatoxins, hepatocellular carcinoma and public health. World Journal of Gastroenterology 19(10):1508– 1512. https://doi.org/10.3748/wjg.v19.i10.1508.
Mittal SH and El-Serag HB. 2013. Epidemiology of HCC: consider the population. J Clin Gastroenterol 47:S2-S6. DOI: 10.1097/MCG.0b013e3182872f29.
Nowicki TK, Markiet K, Szurowska. 2017. Diagnostic imaging of hepatocellular carcinoma - a pictorial essay. Current Medical Imaging Reviews 13(2):140-153. https://doi.org/10.2174/1573405612666160720123748.
Ogunwobi O, Harricharran T, Huaman J, et al. 2019. Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology 25(19):2279-2293. DOI: 10.3748/wjg.v25.i19.2279.
Purba S and Rey I. 2018. Profile and risk factor of hepatocellular carcinoma patients. Proceedings of the International Conference of Science, Technology, Engineering, Environmental and Ramification Researches 1:425-428. DOI: 10.5220/001007204250428.
Puri DA, Murti S, Riastiti Y. 2021. Insidensi dan karakteristik karsinoma hepatoseluler di RSUD Abdul Wahab Sjahranie Samarinda. Jurnal Sains dan Kesehatan 3(2):158-164. https://doi.org/10.25026/jsk.v3i2.275.
Rahmawati AAA dan Samad IA. 2019. Correlation between alpha fetoprotein and platelet profile in hepatocellular carcinoma. Indonesian Journal of Clinical Pathology and Medical Laboratory 26(1):87- 90. http://dx.doi.org/10.24293/ijcpml.v26i1.1353.
Siddiqui MA, Siddiqui HH, Mishra A, et al. 2018. Epidemiology of hepatocellular carcinoma. International Journal of Pharmaceutical Sciences and Research 9(12):5050-5059. DOI:10.13040/IJPSR.0975-8232.9(12).5050-59.
Singal A, Waljee A, Patel N, et al. 2013. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. Journal of the National Comprehensive Cancer Network 11(9):1101-1108. DOI: 10.6004/jnccn.2013.0131.
Sung H, Ferlay J, Siegel R, et al. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer Journal for Clinicians 71(3):209-249. DOI: 10.3322/caac.21660.
Suresh D, Srinivas AN, Kumar DP. 2020. Etiology of hepatocellular carcinoma: special focus on fatty liver disease. Frontiers in Oncology 10:601710. https://doi.org/10.3389/fonc.2020.601710.
Turati F, Talamini R, Pelucchi C, et al. 2013. Metabolic syndrome and hepatocellular carcinoma risk. British Journal of Cancer 108(1):222-228. DOI: 10.1038/bjc.2012.492.
Yang JD, Hainaut P, Gores GJ, et al. 2019. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology 16(10):589– 604. https://doi.org/10.1038/s41575-019-0186-y.
Yehia S, Morad W, Hendy O, et al. 2020. Effect of health education intervention on hepatocellular carcinoma risk factor prevention in Menoufia governorate, Egypt. Egyptian Liver Journal 10(1). https://doi.org/10.1186/s43066-019-0011-x.
Zhang L, Lv Y, Xu AM, et al. 2019. The prognostic significance of serum gamma- glutamyltransferase levels and AST/ALT in primary hepatic carcinoma. BMC Cancer 19:841. https://doi.org/10.1186/s12885- 019-6011-8.
Zhu RX, Seto W, Lai C, et al. 2016. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut and Liver 10(3):332-339. DOI: 10.5009/gnl15257.
Copyright (c) 2023 Shahnaz Azzahra, Ulfa Kholili, Rosy Setiawati, Ummi Maimunah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).